Free Trial

Scancell (SCLP) Competitors

Scancell logo
GBX 10.30 +0.30 (+3.00%)
As of 11:19 AM Eastern

SCLP vs. HZD, PRTC, VRP, AVCT, FARN, ARIX, CIR, 4BB, BVXP, and TILS

Should you be buying Scancell stock or one of its competitors? The main competitors of Scancell include Horizon Discovery Group plc (HZD.L) (HZD), PureTech Health (PRTC), Verona Pharma plc (VRP.L) (VRP), Avacta Group (AVCT), Faron Pharmaceuticals Oy (FARN), Arix Bioscience (ARIX), Circassia Group (CIR), 4basebio (4BB), Bioventix (BVXP), and Tiziana Life Sciences (TILS). These companies are all part of the "biotechnology" industry.

Scancell vs. Its Competitors

Scancell (LON:SCLP) and Horizon Discovery Group plc (HZD.L) (LON:HZD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

In the previous week, Scancell had 7 more articles in the media than Horizon Discovery Group plc (HZD.L). MarketBeat recorded 7 mentions for Scancell and 0 mentions for Horizon Discovery Group plc (HZD.L). Scancell's average media sentiment score of 1.09 beat Horizon Discovery Group plc (HZD.L)'s score of 0.00 indicating that Scancell is being referred to more favorably in the media.

Company Overall Sentiment
Scancell Positive
Horizon Discovery Group plc (HZD.L) Neutral

0.9% of Scancell shares are owned by institutional investors. 15.2% of Scancell shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Scancell's return on equity of 98.74% beat Horizon Discovery Group plc (HZD.L)'s return on equity.

Company Net Margins Return on Equity Return on Assets
ScancellN/A 98.74% -45.28%
Horizon Discovery Group plc (HZD.L) N/A N/A N/A

Horizon Discovery Group plc (HZD.L) has higher revenue and earnings than Scancell. Scancell is trading at a lower price-to-earnings ratio than Horizon Discovery Group plc (HZD.L), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scancell£4.71M22.69-£6.75M-£0.02-495.19
Horizon Discovery Group plc (HZD.L)£54.63M0.00N/A-£5.50N/A

Summary

Scancell beats Horizon Discovery Group plc (HZD.L) on 6 of the 9 factors compared between the two stocks.

Get Scancell News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCLP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SCLP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SCLP vs. The Competition

MetricScancellBiotechnology IndustryMedical SectorLON Exchange
Market Cap£106.89M£237.84M£5.77B£2.57B
Dividend YieldN/A3.78%5.74%5.31%
P/E Ratio-495.1940.7057.775,427.87
Price / Sales22.694,907.50538.4197,460.80
Price / Cash7.8613.1937.1727.93
Price / Book-26.42136.7513.839.27
Net Income-£6.75M-£90.99M£3.29B£5.89B
7 Day Performance28.75%0.77%0.93%0.77%
1 Month Performance-6.28%19.72%5.31%44.86%
1 Year Performance-32.73%803.31%84.25%183.55%

Scancell Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SCLP
Scancell
N/AGBX 10.30
+3.0%
N/A-38.1%£106.89M£4.71M-495.1951News Coverage
Positive News
Earnings Report
Insider Trade
Gap Up
HZD
Horizon Discovery Group plc (HZD.L)
N/AN/AN/AN/A£302.98M£54.63M-33.55416
PRTC
PureTech Health
2.1136 of 5 stars
GBX 114.20
-1.0%
GBX 455
+298.4%
N/A£276.00M£6.17M671.76300
VRP
Verona Pharma plc (VRP.L)
N/AN/AN/AN/A£228MN/A-1.6822Gap Up
AVCT
Avacta Group
N/AGBX 55
flat
N/A-16.9%£220.97M£113K-358.54120
FARN
Faron Pharmaceuticals Oy
N/AGBX 184.50
-1.6%
N/A-16.1%£206.56MN/A-683.3334Gap Down
ARIX
Arix Bioscience
N/AN/AN/AN/A£183.73M£14.16M1,290.919
CIR
Circassia Group
N/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down
4BB
4basebio
1.5208 of 5 stars
GBX 850
-0.6%
GBX 1,600
+88.2%
-43.5%£131.62M£933K-904.26101News Coverage
BVXP
Bioventix
N/AGBX 2,448.50
+0.3%
N/A-33.7%£127.93M£13.66M1,653.0512News Coverage
TILS
Tiziana Life Sciences
N/AN/AN/AN/A£113.85M-£3.60M-3.5911Positive News

Related Companies and Tools


This page (LON:SCLP) was last updated on 9/18/2025 by MarketBeat.com Staff
From Our Partners